Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Delayed Quote. Delayed Xetra - 10/22 11:35:27 am
202.4 EUR   -0.49%
10/22MERCK : Moody's Raises Merck KGaA's Rating to A3 on Improved Business Profile
MT
10/21MARKETMIND : Back to the blues
RE
10/20MERCK KGAA : Barclays takes a positive view
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck : Trade Limitations Force Vaccine Producers To Rethink Supply Chain

09/17/2021 | 04:46am EDT


© MT Newswires 2021
All news about MERCK KGAA
10/22MERCK : Moody's Raises Merck KGaA's Rating to A3 on Improved Business Profile
MT
10/21MARKETMIND : Back to the blues
RE
10/20MERCK KGAA : Barclays takes a positive view
MD
10/20CytoReason Collaborates with Merck KGaA on Cancer Immunotherapy Drug
CI
10/20MARKETMIND : Margin pressures
RE
10/19MARKETMIND : Fast and furious
RE
10/14MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German Securities..
EQ
10/14MERCK : EMD Serono, Inc. - New Real-World MAVENCLAD Data Show Sustained Effectiveness and ..
AQ
10/13Merck KGaA's Multiple Sclerosis Treatment Drug Shows Improved Quality Of Life In Study
MT
10/13MERCK KGAA : JP Morgan reaffirms its Buy rating
MD
More news
Analyst Recommendations on MERCK KGAA
More recommendations
Financials
Sales 2021 19 375 M 22 558 M 22 558 M
Net income 2021 2 765 M 3 219 M 3 219 M
Net Debt 2021 8 932 M 10 400 M 10 400 M
P/E ratio 2021 31,5x
Yield 2021 0,76%
Capitalization 87 999 M 102 B 102 B
EV / Sales 2021 5,00x
EV / Sales 2022 4,59x
Nbr of Employees 58 408
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | MarketScreener
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 202,40 €
Average target price 200,03 €
Spread / Average Target -1,17%
EPS Revisions
Managers and Directors
Belén Garijo López Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Maria Rivas Chief Medical Officer & Senior Vice President
Laura Matz Chief Science & Technology Officer
Sector and Competitors